There is abundant evidence that the risk of atherosclerotic vascular disease is directly related
to plasma cholesterol levels. Accordingly, all of the national and transnational screening …

Lipoprotein lipase (LPL; EC 3.1.1.34) is a key enzyme in the metabolism of lipids. Many
diseases, including obesity, coronary heart disease, chylomicronemia (pancreatitis), and …

In everyday life, the outcomes of our actions are rarely certain. Further, we often lack the
information needed to precisely estimate the probability and value of potential outcomes as well …

… C by an additional 20.5% (P=0.0001) versus statin-80. Similar significant reductions in LDL-C
… HoFH produced clinically important LDL-C reductions compared with best current therapy. …

DEAP is a novel evolutionary computation framework for rapid prototyping and testing of ideas.
Its design departs from most other existing frameworks in that it seeks to make algorithms …

To comprehend a nonpredicating combination involving a modifier (eg, mountain) and a
head noun (eg, stream), one must specify a thematic relation (eg, a stream in the mountains) …

… lower LDL-C in HeFH … -C ≥2.6 mmol/L (≥100 mg/dL) to weekly subcutaneous mipomersen
200 mg or placebo (2:1) for 26 weeks. The primary end point was percent change in LDL-C …

… C-reactive protein was also measured at visits 3 and 6. The percentage of patients who
achieved NCEP ATP II target levels for LDL cholesterol at end point (after 8 weeks of treatment) …

Evolution provides a creative fount of complex and subtle adaptations that often surprise the
scientists who discover them. However, the creativity of evolution is not limited to the natural …

In the decades of the 1990s many mental health programs and the systems that fund these
programs have identified themselves as recovery-oriented. A program that is grounded in a …